Hsa_circ_0007637 Facilitates Nasopharyngeal Carcinoma Progression by Sponging miR-636/TPD52 Axis

References

• Yin L, Chen J, Ma C, et al. Hsa_circ_0046263 functions as a ceRNA to promote nasopharyngeal carcinoma progression by upregulating IGFBP3. Cell Death Dis. 2020;11(7):562. doi:10.1038/s41419-020-02785-332703944
   PubMed Web of Science ®Google Scholar
• Lam WKJ, Chan JYK. Recent advances in the management of nasopharyngeal carcinoma. F1000Res. 2018;7:F1000 Faculty Rev–1829.
   PubMedGoogle Scholar
• Guo R, Mao YP, Tang LL, et al. The evolution of nasopharyngeal carcinoma staging. Br J Radiol. 2019;92(1102):20190244. doi:10.1259/bjr.2019024431298937
   PubMed Web of Science ®Google Scholar
• Ke KJ, Wang CY, Li P, et al. Hsa_circ_001193 regulates proliferation and apoptosis of nasopharyngeal carcinoma cells through targeting mir-496. Eur Rev Med Pharmacol Sci. 2020;24(6):3069–3076.32271424
   PubMed Web of Science ®Google Scholar
• Zhong Y, Du Y, Yang X, et al. Circular RNAs function as ceRNAs to regulate and control human cancer progression. Mol Cancer. 2018;17(1):79. doi:10.1186/s12943-018-0827-829626935
   PubMed Web of Science ®Google Scholar
• Yang X, Ye T, Liu H, et al. Expression profiles, biological functions and clinical significance of circRNAs in bladder cancer. Mol Cancer. 2021;20(1):4. doi:10.1186/s12943-020-01300-833397425
   PubMed Web of Science ®Google Scholar
• Fang Q, Liu H, Zhou A, et al. Circ_0046599 promotes the development of hepatocellular carcinoma by regulating the miR-1258/RPN2 network. Cancer Manag Res. 2020;12:6849–6860. doi:10.2147/CMAR.S25351032801909
   PubMed Web of Science ®Google Scholar
• He Y, Wang Y, Liu L, et al. Circular RNA circ_0006282 contributes to the progression of gastric cancer by sponging miR-155 to upregulate the expression of FBXO22. Onco Targets Ther. 2020;13:1001–1010. doi:10.2147/OTT.S22821632099403
   PubMed Web of Science ®Google Scholar
• Wu H, Liu Y, Duan H, et al. Identification of differentially expressed circular RNAs in human nasopharyngeal carcinoma. Cancer Biomark. 2020;29(4):483–492. doi:10.3233/CBM-20173132865182
   PubMed Web of Science ®Google Scholar
• Chen QN, Chen X, Chen ZY, et al. Long intergenic non-coding RNA 00152 promotes lung adenocarcinoma proliferation via interacting with EZH2 and repressing IL24 expression. Mol Cancer. 2017;16(1):17. doi:10.1186/s12943-017-0581-328109288
   PubMed Web of Science ®Google Scholar
• Wu Y, Xie Z, Chen J, et al. Circular RNA circTADA2A promotes osteosarcoma progression and metastasis by sponging miR-203a-3p and regulating CREB3 expression. Mol Cancer. 2019;18(1):73. doi:10.1186/s12943-019-1007-130940151
   PubMed Web of Science ®Google Scholar
• Xiao Z, Qiu Y, Lin Y, et al. Blocking lncRNA H19-miR-19a-Id2 axis attenuates hypoxia/ischemia induced neuronal injury. Aging. 2019;11(11):3585–3600. doi:10.18632/aging.10199931170091
   PubMedGoogle Scholar
• Duan ZN, Dong CG, Liu JH. Circ-ABCB10 promotes growth and metastasis of nasopharyngeal carcinoma by upregulating ROCK1. Eur Rev Med Pharmacol Sci. 2020;24(23):12208–12215.33336739
   PubMed Web of Science ®Google Scholar
• Li S, Wang Q. Hsa_circ_0081534 increases the proliferation and invasion of nasopharyngeal carcinoma cells through regulating the miR-508-5p/FN1 axis. Aging. 2020;12(20):20645–20657. doi:10.18632/aging.10396333082297
   PubMedGoogle Scholar
• Li M, Li Y, Yu M. CircRNA ZNF609 knockdown suppresses cell growth via modulating miR-188/ELF2 axis in nasopharyngeal carcinoma. Onco Targets Ther. 2020;13:2399–2409. doi:10.2147/OTT.S23423032273713
   PubMed Web of Science ®Google Scholar
• Liu R, Zhou M, Zhang P, et al. Cell proliferation and invasion is promoted by circSERPINA3 in nasopharyngeal carcinoma by regulating miR-944/MDM2 axis. J Cancer. 2020;11(13):3910–3918. doi:10.7150/jca.4279932328195
   PubMed Web of Science ®Google Scholar
• Qiongna D, Jiafeng Z, Yalin H, et al. Implication of hsa_circ_0028007 in reinforcing migration, invasion, and chemo-tolerance of nasopharyngeal carcinoma cells. J Clin Lab Anal. 2020;34(9):e23409. doi:10.1002/jcla.2340932524687
   PubMed Web of Science ®Google Scholar
• Wang J, Kong J, Nie Z, et al. Circular RNA Hsa_circ_0066755 as an oncogene via sponging miR-651 and as a promising diagnostic biomarker for nasopharyngeal carcinoma. Int J Med Sci. 2020;17(11):1499–1507. doi:10.7150/ijms.4702432669952
   PubMed Web of Science ®Google Scholar
• Zhu L, Liu Y, Yang Y, et al. CircRNA ZNF609 promotes growth and metastasis of nasopharyngeal carcinoma by competing with microRNA-150-5p. Eur Rev Med Pharmacol Sci. 2019;23(7):2817–2826.31002133
   PubMed Web of Science ®Google Scholar
• Guo DQ, Liu F, Zhang L, et al. CircPSMC3 inhibits cell proliferation and induces cell apoptosis in nasopharyngeal carcinoma by downregulating ROCK1. Eur Rev Med Pharmacol Sci. 2020;24(20):10306.33155260
   PubMed Web of Science ®Google Scholar
• Li W, Lu H, Wang H, et al. Circular RNA TGFBR2 acts as a ceRNA to suppress nasopharyngeal carcinoma progression by sponging miR-107. Cancer Lett. 2021;499:301–313. doi:10.1016/j.canlet.2020.11.00133160003
   PubMed Web of Science ®Google Scholar
• Hu QL, Xu ZP, Lan YF, et al. miR-636 represses cell survival by targeting CDK6/Bcl-2 in cervical cancer. Kaohsiung J Med Sci. 2020;36(5):328–335. doi:10.1002/kjm2.1218131889428
   PubMed Web of Science ®Google Scholar
• Chen CL, Lin CH, Li AL, et al. Plasma miRNA profile is a biomarker associated with urothelial carcinoma in chronic hemodialysis patients. Am J Physiol Renal Physiol. 2019;316(6):F1094–F1102. doi:10.1152/ajprenal.00014.201930892932
   PubMed Web of Science ®Google Scholar
• Song J, Shi W, Gao Z, et al. Downregulation of circRNA_100876 inhibited progression of NSCLC in vitro via targeting miR-636. Technol Cancer Res Treat. 2020;19:1533033820951817. doi:10.1177/153303382095181733030101
   PubMed Web of Science ®Google Scholar
• He Q, Huang L, Yan D, et al. CircPTPRA acts as a tumor suppressor in bladder cancer by sponging miR-636 and upregulating KLF9. Aging. 2019;11(23):11314–11328. doi:10.18632/aging.10253031821171
   PubMedGoogle Scholar
• Wang Y, Chen CL, Pan QZ, et al. Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma. Oncotarget. 2016;7(5):6323–6334. doi:10.18632/oncotarget.631926575170
   PubMedGoogle Scholar
• Wang Z, Li Y, Fan L, et al. Silencing of TPD52 inhibits proliferation, migration, invasion but induces apoptosis of pancreatic cancer cells by deactivating Akt pathway. Neoplasma. 2020;67(2):277–285. doi:10.4149/neo_2019_190404N29531847526
   PubMed Web of Science ®Google Scholar
• Roslan N, Bièche I, Bright RK, et al. TPD52 represents a survival factor in ERBB2-amplified breast cancer cells. Mol Carcinog. 2014;53(10):807–819. doi:10.1002/mc.2203823661506
   PubMed Web of Science ®Google Scholar
• Li J, Li Y, Liu H, et al. The four-transmembrane protein MAL2 and tumor protein D52 (TPD52) are highly expressed in colorectal cancer and correlated with poor prognosis. PLoS One. 2017;12(5):e0178515. doi:10.1371/journal.pone.017851528562687
   PubMed Web of Science ®Google Scholar
• Yin W, Shi L, Mao Y. MicroRNA-449b-5p suppresses cell proliferation, migration and invasion by targeting TPD52 in nasopharyngeal carcinoma. J Biochem. 2019;166(5):433–440. doi:10.1093/jb/mvz05731350893
   PubMed Web of Science ®Google Scholar
• Zhao X, Chu J. MicroRNA-379 suppresses cell proliferation, migration and invasion in nasopharyngeal carcinoma by targeting tumor protein D52. Exp Ther Med. 2018;16(2):1232–1240.30116374
   PubMed Web of Science ®Google Scholar
• Gao R, Feng Q, Tan G. microRNA-613 exerts anti-angiogenic effect on nasopharyngeal carcinoma cells through inactivating the AKT signaling pathway by down-regulating FN1. Biosci Rep. 2019;39(7):BSR20182196. doi:10.1042/BSR2018219631189740
   PubMed Web of Science ®Google Scholar
• Zuo WN, Zhu H, Li LP, et al. MiR-155 promotes proliferation and inhibits apoptosis of nasopharyngeal carcinoma cells through targeting PTEN-PI3K/AKT pathway. Eur Rev Med Pharmacol Sci. 2019;23(18):7935–7942.31599418
   PubMed Web of Science ®Google Scholar